Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Christoph

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Pain Practice : the Official Journal of World Institute of Pain|January 24, 2017
Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic PainThomas M Tzschentke, Klaus Linz, Stefanie Frosch, et al.
Drugs in R&D|January 26, 2007
Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain modelsThomas Christoph, Babette Kögel, Wolfgang Strassburger, et al.
Neuroscience Letters|January 15, 2011
The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (μ-opioid receptor) knockout miceBabette Kögel, Jean De Vry, Thomas M Tzschentke, et al.
Biochemical and Biophysical Research Communications|April 17, 2018
Investigation of TRPV1 loss-of-function phenotypes in TRPV1 Leu206Stop mice generated by N-ethyl-N-nitrosourea mutagenesisThomas Christoph, Babette Kögel, Klaus Schiene, et al.
European Journal of Pharmacology|August 30, 2014
Pharmacogenomic study of the role of the nociceptin/orphanin FQ receptor and opioid receptors in diabetic hyperalgesiaKris Rutten, Thomas M Tzschentke, Thomas Koch, et al.
Brain Research|June 1, 2005
Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanismsThomas Christoph, Elke Reissmüller, Klaus Schiene, et al.
European Journal of Pharmacology|March 11, 2018
Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic painKris Rutten, Wolfgang Schröder, Thomas Christoph, et al.
European Journal of Pain (London, England)|June 15, 2010
Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic painWolfgang Schröder, Jean De Vry, Thomas M Tzschentke, et al.
British Journal of Pharmacology|June 19, 2003
Actions of tramadol on micturition in awake, freely moving ratsRaj Kumar Pandita, Rikard Pehrson, Thomas Christoph, et al.
Neuropharmacology|April 18, 2006
The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonismThomas Christoph, Klaus Schiene, Werner Englberger, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Pain Practice : the Official Journal of World Institute of Pain|January 24, 2017
Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic PainThomas M Tzschentke, Klaus Linz, Stefanie Frosch, et al.
Drugs in R&D|January 26, 2007
Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain modelsThomas Christoph, Babette Kögel, Wolfgang Strassburger, et al.
Neuroscience Letters|January 15, 2011
The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (μ-opioid receptor) knockout miceBabette Kögel, Jean De Vry, Thomas M Tzschentke, et al.
Biochemical and Biophysical Research Communications|April 17, 2018
Investigation of TRPV1 loss-of-function phenotypes in TRPV1 Leu206Stop mice generated by N-ethyl-N-nitrosourea mutagenesisThomas Christoph, Babette Kögel, Klaus Schiene, et al.
European Journal of Pharmacology|August 30, 2014
Pharmacogenomic study of the role of the nociceptin/orphanin FQ receptor and opioid receptors in diabetic hyperalgesiaKris Rutten, Thomas M Tzschentke, Thomas Koch, et al.
Brain Research|June 1, 2005
Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanismsThomas Christoph, Elke Reissmüller, Klaus Schiene, et al.
European Journal of Pharmacology|March 11, 2018
Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic painKris Rutten, Wolfgang Schröder, Thomas Christoph, et al.
European Journal of Pain (London, England)|June 15, 2010
Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic painWolfgang Schröder, Jean De Vry, Thomas M Tzschentke, et al.
British Journal of Pharmacology|June 19, 2003
Actions of tramadol on micturition in awake, freely moving ratsRaj Kumar Pandita, Rikard Pehrson, Thomas Christoph, et al.
Neuropharmacology|April 18, 2006
The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonismThomas Christoph, Klaus Schiene, Werner Englberger, et al.
Pageof 8